Biology Reference
In-Depth Information
Fehniger TA, Herbein G, Yu H, Para MI, Bernstein ZP, O'Brien WA, Caligiuri MA. 1998. Natural
killer cells from HIV-1
patients produce C-C chemokines and inhibit HIV-1 infection. J Im-
munol 161: 6433±6438.
Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M,
Tursz T, Maraskovsky E, Zitvogel L. 1999. Dendritic cells directly trigger NK cell functions:
cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5: 405±411.
Fontana L, Sirianni MC, de Sanctis G, Carbonari M, Ensoli B, Aiuti F. 1986. De®ciency of natural
killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome
positive for antibodies to HTLV-III. Immunobiology 171: 425±435.
Forthal DN, Landucci G, Haubrich R, Keenan B, Kuppermann BD, Tilles JG, Kaplan J. 1999.
Antibody-dependent cellular cytotoxicity independently predicts survival in severely immuno-
compromised human immunode®ciency virus-infected patients. J Infect Dis 180: 1338±1341.
Galiani MD, Aguado E, Tarazona R, Romero P, Molina I, Santamaria M, Solana R, Pena J. 1999.
Expression of killer inhibitory receptors on cytotoxic cells from HIV-1-infected individuals. Clin
Exp Immunol 115: 472±476.
Geertsma MF, Stevenhagen A, van Dam EM, Nibbering PH. 1999. Expression of zeta molecules is
decreased in NK cells from HIV-infected patients. FEMS Immunol Med Microbiol 26: 249±257.
Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A. 1994. The Ikaros
gene is required for the development of all lymphoid lineages. Cell 79: 143±156.
Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW.
1997. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes,
monocyte-derived dendritic cells, and natural killer cells. J Exp Med 185: 1595±1604.
Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu Y, Menon S, Abrams J, Handel T, Zlotnik A.
1997. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J
Immunol 158: 1533±1540.
Herberman RB, Nunn ME, Lavrin DH. 1975. Natural cytotoxic reactivity of mouse lymphoid cells
against syngeneic acid allogeneic tumors. I. Distribution of reactivity and speci®city. Int J Can-
cer 16: 216±229.
Hober D, Jewett A, Bonavida B. 1995. Lysis of uninfected HIV-1 gpl120-coated peripheral blood-
derived T lymphocytes by monocyte-mediated antibody-dependent cellular cytotoxicity. FEMS
Immunol Med Microbiol 10: 83±92.
Hu PF, Hultin LE, Hultin P, Hausner MA, Hirji K, Jewett A, Bonavida B, Detels R, Giorgi JV.
1995. Natural killer cell immunode®ciency in HIV disease is manifest by profoundly decreased
numbers of CD16
CD56
cells and expansion of a population of CD16
dim
CD56
ÿ
cells with
low lytic activity. J Acquir Immune De®c Syndr Hum Retrovirol 10: 331±340.
Jassoy C, Harrer T, Rosenthal T, Navia BA, Worth J, Johnson RP, Walker BD. 1993. Human
immunode®ciency virus type 1-speci®c cytotoxic T lymphocytes release gamma interferon,
tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target
antigens. J Virol 67: 2844±2852.
Jewett A, Bonavida B. 1990. Peripheral blood monocytes derived from HIV
individuals mediate
antibody-dependent cellular cytotoxicity (ADCC). Clin Immunol Immunopathol 54: 192±199.
Jewett A, Bonavida B. 1995a. Target-induced anergy of natural killer cytotoxic function is restricted
to the NK-target conjugate subset. Cell Immunol 160: 91±97.
Jewett A, Bonavida B. 1995b. Interferon-alpha activates cytotoxic function but inhibits interleukin-
2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural
killer cells. J Clin Immunol 15: 35±44.
Jewett A, Bonavida B. 1996. Target-induced inactivation and cell death by apoptosis in a subset of
human NK cells. J Immunol 156: 907±915.
Jewett A, Giorgi JV, Bonavida B. 1990. Antibody-dependent cellular cytotoxicity against HIV-
coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
J Immunol 145: 4065±4071.
